Advances in Pharmacogenomics of Human Diseases
A special issue of Genes (ISSN 2073-4425). This special issue belongs to the section "Pharmacogenetics".
Deadline for manuscript submissions: 20 June 2025 | Viewed by 146
Special Issue Editors
2. Research Group of Clinical Pharmacology and Pharmacogenomics, Faculty of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens, 15771 Athens, Greece
Interests: clinical pharmacology; pharmacogenomics; pharmacogenetics; personalised medicine; biomarkers
Special Issue Information
Dear Colleagues,
Pharmacogenomics, a cornerstone of precision medicine, is transforming the landscape of modern medicine by uncovering how genetic variations influence drug efficacy and safety. These insights are paving the way for more personalized therapeutic strategies, improving drug efficacy, minimizing adverse drug reactions, and optimizing clinical outcomes. Despite its potential, the full implementation of pharmacogenomics in clinical practice remains limited, with challenges such as biomarker validation and integration into healthcare systems yet to be fully addressed. This Special Issue aims to provide a comprehensive overview of the latest research in pharmacogenomics and its application to human diseases. We invite high-quality original research articles and comprehensive reviews addressing, but not limited to, pharmacogenomic biomarker identification and validation, novel approaches for integrating pharmacogenomics into clinical workflows, and bioinformatics tools that enhance the interpretation of genetic data. These efforts will collectively contribute to bridging the gap between pharmacogenomics research and clinical practice, improving the quality of patient care.
Dr. Maria Papasavva
Dr. Alexander Haliassos
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Genes is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pharmacogenomics
- precision medicine
- genetic variants
- disease susceptibility
- clinical genetics
- individualized treatment
- biomarkers
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
